On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Categories: Health & Fitness, News
Tags: cagrisema, glp1, health, Health & Fitness, health and wellness, Medicine, obesity, Orforglipron, ozempic, retatrutide, Rybelsus, Wegovy, zepbound